Company / Operating Cash Flow per Share
GeneDx Holdings Corp. Operating Cash Flow per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$1.19
FY2025
5-year range
-$1535758.06 / $1.19
FY2021-FY2025
Trend
+208.3%
vs FY2024
Sector context
#107 of 155
Health Care
What the data says
Operating Cash Flow per Share changed +208% YoY in FY2025, a notable deviation from the 6-year average annual change of -1296%.
Based on SEC 10-K filings.
1.19 in FY2025.
Improved from $-15.30 to $1.19 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#107 of 155 in Health CareTop 69% of 155This company $1.19 Sector average $6.77
▼
-82.5% below sector average
Key checks
Key Insights
- GeneDx Holdings Corp.'s operating cash flow per share has grown for 4 consecutive years.
- In FY2025, operating cash flow per share increased 208.3% year-over-year.
- Ranks #107 out of 155 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- Negative profit margin: -17.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.19 | +208.3% |
| FY2024 | -$1.10 | +92.8% |
| FY2023 | -$15.30 | +100.0% |
| FY2022 | -$62201.33 | +95.9% |
| FY2021 | -$1535758.06 | -8361.4% |
| FY2020 | -$18150.07 | +88.0% |
| FY2019 | -$151032.26 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026